COSM insider Grigorios Siokas gets 61,614 shares for $40K debt

Rhea-AI Filing Summary

Cosmos Health Inc. (COSM) disclosed that its Chief Executive Officer, director and 10% owner, Grigorios Siokas, acquired additional common shares through a debt-for-equity exchange. On November 19, 2025, he acquired 61,614 shares of common stock at $0.6492 per share, described as the fair market value of the stock on that date. The shares were issued in exchange for a total of $40,000 that the company owed to Mr. Siokas under a debt exchange agreement. Following this transaction, he beneficially owns 6,220,498 common shares directly.

Insider Trade Summary

Net Buyer: 61,614 shares ($40,000)

Net Buy 1 txn

Insider Siokas Grigorios

Role Chief Executive Officer

Bought 61,614 shs ($40K)

Type	Security	Shares	Price	Value
Purchase	Common Stock, par value $.001	61,614	$0.6492	$40K

Holdings After Transaction: Common Stock, par value $.001 — 6,220,498 shares (Direct)

Footnotes (1)

1. [object Object]

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 11/20/2025 - 11:06 AM Learn about SEC filing dates

FAQ

What insider transaction did Cosmos Health (COSM) report for its CEO?

Cosmos Health reported that CEO, director and 10% owner Grigorios Siokas acquired 61,614 shares of common stock on November 19, 2025 through a debt-for-equity exchange.

At what price were the new Cosmos Health (COSM) shares issued to the CEO?

The 61,614 shares of Cosmos Health common stock were issued to Grigorios Siokas at $0.6492 per share, which is described as the fair market value on November 19, 2025.

What company obligation was exchanged for Cosmos Health (COSM) shares to the CEO?

The shares were issued as Exchange Shares in return for a total of $40,000 that Cosmos Health owed to Grigorios Siokas, under a debt exchange agreement between him and the company.

How many Cosmos Health (COSM) shares does the CEO own after this transaction?

After the reported transaction, CEO Grigorios Siokas beneficially owns 6,220,498 shares of Cosmos Health common stock in direct ownership.

What is the role of Grigorios Siokas at Cosmos Health (COSM)?

Grigorios Siokas is a Director, Chief Executive Officer, and a reported 10% Owner of Cosmos Health Inc.

What SEC form was used to disclose this Cosmos Health (COSM) insider transaction?

The transaction by Cosmos Health CEO Grigorios Siokas was disclosed on Form 4, which reports changes in beneficial ownership by company insiders.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Siokas Grigorios

(Last) (First) (Middle)

5 AG. GEORGIOU STR

PILEA

(Street)

THESSALONIKI J3 TK57001

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Cosmos Health Inc. [ COSM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/19/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $.001	11/19/2025	11/19/2025	P(1)		61,614	A	$0.6492	6,220,498	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares are Exchange Shares being acquired by Grigorios Siokas, the Company's CEO, at the Exchange Rate of $0.6492 per share, the fair market value of the Common Stock on November 19, 2025, as an exchange to a total amount of $40,000 the Company owed to Mr. Siokas, pursuant to a debt exchange agreement between him and the Company.

Remarks:

	/s/ Grigorios Siokas	11/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.